References
World Health Organization. The importance of caregiver-child interactions for the survival and healthy development of young children: A review. WHO; 2004.
Ranson KE, Urichuk LJ. The effect of parent-child attachment relationships on child biopsychosocial outcomes: A review. Early Child Dev Care. 2008;178:129–52.
Coan JA. Adult attachment and the brain. J Soc Pers Relat. 2010 Mar;27(2):210–7.
Davis M, Bilms J, Suveg C. In Sync and in Control: A Meta-Analysis of Parent–Child Positive Behavioral Synchrony and Youth Self-Regulation. Fam Process. 2017;56(4):962–80.
Maunder R, Monks CP. Friendships in middle childhood: Links to peer and school identification, and general self-worth. Brit J Dev Psychol. 2019;37(2):211–29.
Boele S, Van der Graaff J, de Wied M, Van der Valk IE, Crocetti E, Branje S. Linking Parent–Child and Peer Relationship Quality to Empathy in Adolescence: A Multilevel Meta-Analysis. J Youth Adolescence. 2019 Jun 1;48(6):1033–55.
Kluczniok D, Boedeker K, Hindi Attar C, Jaite C, Bierbaum AL, Fuehrer D, et al. Emotional availability in mothers with borderline personality disorder and mothers with remitted major depression is differently associated with psychopathology among school-aged children. J Affect Disord. 2018 Apr 15;231:63–73.
Hughes AE, Crowell SE, Uyeji L, Coan JA. A Developmental Neuroscience of Borderline Pathology: Emotion Dysregulation and Social Baseline Theory. J Abnorm Child Psychol. 2012 Jan;40(1):21–33.
Criss MM, Pettit GS, Bates JE, Dodge KA, Lapp AL. Family Adversity, Positive Peer Relationships, and Children’s Externalizing Behavior: A Longitudinal Perspective on Risk and Resilience. Child Dev. 2002;73(4):1220–37.
Hazel N, Oppenheimer C, Technow J, Young J, Hankin B. Parent relationship quality buffers against the effect of peer stressors on depressive symptoms from middle childhood to adolescence. Dev Psychol. 2014 Aug;50(8):2115–23.
Evers O, Georg AK, Wegener C, Sidor A, Taubner S. Transactional Relations between Child Functioning and Parenting Stress in the First Years of Life: A Longitudinal Study among Psychosocially Burdened Families. Psychopathology. 2022 May 10:1–12.
Dittmann D, Reindl V, Herpertz-Dahlmann B, Dahmen B, Firk C, Borzikowsky C, et al. Challenging the Sensitive Window Hypothesis: Timing Effects of Maternal Depressive Symptoms on the Intergenerational Transmission of Maltreatment and Psychopathology in the Next Generation. Psychopathology. 2022 Aug 2:1–15.
Reck C, Hagl M, Ohlrich R, Zietlow AL. From Interactive Regulation in Infancy to Relationship-Focused Interventions. Psychopathology. 2022 Jul 14:1–11.
Franssens R, Giletta M, Vanwoerden S, Clercq BD. Bullying Perpetration and Victimization as Social Mechanisms in the Development of Borderline Personality Traits during Adolescence: A Longitudinal Study. Psychopathology. 2022 Mar 16:1–7.
Steinhoff A, Ribeaud D, Eisner M, Shanahan L. Developmental Trajectories of Self-, Other-, and Dual-Harm across Adolescence: The Role of Relationships with Peers and Teachers. Psychopathology. 2022 Jun 30:1–10.
Author Contacts
Michael Kaess, michael.kaess@upd.ch
Article / Publication Details
Received: January 18, 2023
Accepted: January 18, 2023
Published online: February 14, 2023
Issue release date:
Number of Print Pages: 3
Number of Figures: 0
Number of Tables: 0
ISSN: 0254-4962 (Print)
eISSN: 1423-033X (Online)
For additional information: https://www.karger.com/PSP
Open Access License / Drug Dosage / Disclaimer
This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Comments (0)